5% glucose injection: Clinical Trials

7 trials of 5% glucose injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 2 unknown. 3 Phase 2, 3 Phase 4, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Unknown 1
Phase 43Completed 2, Unknown 1
Not applicable1Recruiting 1
Phase 31Unknown 1

Follow 5% glucose injection: new trials by email Literature Review of 5% glucose injection trials Research Report on 5% glucose injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Shenfu Injection for the Prevention and Treatment of Ventilator Dependence in Mechanically Ventilated Patients
Shenfu Injection, 5% glucose injection - Ventilator-induced Diaphragm Dysfunction, Ventilator Dependence
Not applicableRecruitingThe Fourth Affiliated Hospital of Zhejiang University School of Medicine4002026-04-012026-10-19
Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction
YN001 20mg Dose + 5% glucose injection, 5% glucose injection - Atherosclerotic Cardiovascular Disease (ASCVD), Erectile Dysfunction
Phase 2RecruitingBeijing Inno Medicine Co., Ltd.402026-02-042026-09-22
Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV
levosimendan, 5% glucose injection - Transesophageal Echocardiography, Acute Respiratory Distress Syndrome
Phase 2 / Phase 3UnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology582023-03-222023-03-14
Clinical Efficacy of Megadose Vitamin C in Sepsis
Vitamin C, 5% glucose injection - Sepsis, Septic Shock
Phase 2CompletedZhujiang Hospital2342022-02-082026-05-13
Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury
Shenfu Injection, 5% Glucose Injection - Myocardial Infarction
Phase 4UnknownBeijing Anzhen Hospital3262020-07-302021-09-10
ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction
Shenfu Injection, 5% Glucose Injection - Myocardial Infarction
Phase 4CompletedBeijing Anzhen Hospital402016-04-012018-08-07
A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure
Shenfu Zhusheye, 5% glucose injection - Acute Heart Failure
Phase 4CompletedChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd.3652014-09-032018-03-01

Conditions studied

Myocardial Infarction (2)  ·  Atherosclerosis (1)  ·  Erectile Dysfunction (1)  ·  Reperfusion Injury (1)  ·  Respiratory Distress Syndrome (1)  ·  Sepsis (1)  ·  Shock, Septic (1)  ·  Ventricular Dysfunction, Right (1)

Sponsors

Beijing Anzhen Hospital (2)  ·  Beijing Inno Medicine Co., Ltd. (1)  ·  China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (1)  ·  The Fourth Affiliated Hospital of Zhejiang University School of Medicine (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)  ·  Zhujiang Hospital (1)

Countries

China (7)

Top investigators

Jiefu Yang (1)  ·  Zhanguo Liu, M.D.PhD (1)

Results publications

PMID 34926601, PMID 36822255